Investing.com -- Acrivon Therapeutics Inc (NASDAQ:ACRV) stock plummeted 29.2% Thursday after the clinical-stage biotech company released mixed results from its ongoing cancer treatment trials.

The Trump administration has urged Americans to avoid highly processed foods and added sugars while promoting red meat and ...

As we ring in the new year, cancer survivors on the island of St. Croix can continue to look forward to art classes and other ...

Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large ...

A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

The 2025-2030 Dietary Guidelines for Americans, released Jan. 7, score well for their streamlined approach, for limiting “bad ...

For Cancer natives, this phase brings steady progress, thoughtful planning, and emotional experiences that require sensitivity and balance.

Becomes available free of charge for nine-year-old girls at EPI centres; other provinces expected to follow suit.

Cancer natives experience a period of contrasts, where early confusion gives way to creative opportunities and renewed ...

Know what the year 2026 holds for Cancer natives. Explore Vedic predictions on career, business, health, love life, finances, ...

Cancer Horoscope 2026 brings mixed results with growth, lessons, financial gains, emotional challenges, career progress, and ...